تحميل...
Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ(9)-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans
AIM: Cannabinoid receptor type 1 (CB(1)) antagonists have been developed for the treatment of obesity and associated risk factors. Surinabant is a high affinity CB(1) antagonist in vitro. The aim of this study was to assess the magnitude of inhibition by surinabant of CNS effects and heart rate indu...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Blackwell Science Inc
2013
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3703229/ https://ncbi.nlm.nih.gov/pubmed/23278647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12071 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|